At the time of writing, Alx Oncology Holdings Inc [ALXO] stock is trading at $14.49, up 12.41%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ALXO shares have gain 17.42% over the last week, with a monthly amount glided 28.23%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Alx Oncology Holdings Inc [NASDAQ: ALXO] stock has seen the most recent analyst activity on March 08, 2024, when Stifel downgraded its rating to a Hold and also boosted its price target to $14 from $10. Previously, Jefferies upgraded its rating to Buy on December 08, 2023, and elevated its price target to $18. On December 22, 2021, downgrade downgraded it’s rating to Hold and revised its price target to $25 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $106 on September 30, 2021. In a note dated April 06, 2021, UBS initiated an Buy rating.
For the past year, the stock price of Alx Oncology Holdings Inc fluctuated between $3.94 and $17.42. Currently, Wall Street analysts expect the stock to reach $26 within the next 12 months. Alx Oncology Holdings Inc [NASDAQ: ALXO] shares were valued at $14.49 at the most recent close of the market. An investor can expect a potential return of 79.43% based on the average ALXO price forecast.
Analyzing the ALXO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.66, Equity is -3.15 and Total Capital is -0.82. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.35 points at the first support level, and at 12.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.12, and for the 2nd resistance point, it is at 15.75.
Ratios To Look Out For
It is important to note that Alx Oncology Holdings Inc [NASDAQ:ALXO] has a current ratio of 5.24. Also, the Quick Ratio is 5.24, while the Cash Ratio stands at 0.62.
Transactions by insiders
Recent insider trading involved Pons Jaume, PRESIDENT & CSO, that happened on Apr 04 ’24 when 20000.0 shares were sold. CHIEF EXECUTIVE OFFICER, Lettmann Jason completed a deal on Mar 14 ’24 to buy 4400.0 shares. Meanwhile, SVP, Finance and CAO Pinto Shelly sold 2717.0 shares on Jan 04 ’24.
